225 related articles for article (PubMed ID: 33251342)
1. The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment.
Thomas M; De Roover R; van der Merwe S; Lambrecht M; Defraene G; Haustermans K
Clin Transl Radiat Oncol; 2021 Jan; 26():8-14. PubMed ID: 33251342
[TBL] [Abstract][Full Text] [Related]
2. Setup strategies and uncertainties in esophageal radiotherapy based on detailed intra- and interfractional tumor motion mapping.
Hoffmann L; Poulsen PR; Ravkilde T; Bertholet J; Kruhlikava I; Helbo BL; Schmidt ML; Nordsmark M
Radiother Oncol; 2019 Jul; 136():161-168. PubMed ID: 31015120
[TBL] [Abstract][Full Text] [Related]
3. Translational and rotational intra- and inter-fractional errors in patient and target position during a short course of frameless stereotactic body radiotherapy.
Josipovic M; Persson GF; Logadottir A; Smulders B; Westmann G; Bangsgaard JP
Acta Oncol; 2012 May; 51(5):610-7. PubMed ID: 22263924
[TBL] [Abstract][Full Text] [Related]
4. Residual setup errors in cranial stereotactic radiosurgery without six degree of freedom robotic couch: Frameless versus rigid immobilization systems.
Liu RJ; Yang SX; Neylon J; Hall MD; Dandapani S; Vora N; Wong JYC; Liu A
J Appl Clin Med Phys; 2020 Mar; 21(3):87-93. PubMed ID: 32068342
[TBL] [Abstract][Full Text] [Related]
5. Quantification of Esophageal Tumor Motion and Investigation of Different Image-Guided Correction Strategies.
Voncken FEM; Nakhaee S; Stam B; Wiersema L; Vollenbrock SE; van Dieren JM; van Leerdam ME; Sonke JJ; Aleman BMP; Remeijer P
Pract Radiat Oncol; 2020; 10(2):84-92. PubMed ID: 31786235
[TBL] [Abstract][Full Text] [Related]
6. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
[TBL] [Abstract][Full Text] [Related]
7. Use of implanted gold fiducial markers with MV-CBCT image-guided IMRT for pancreatic tumours.
Packard M; Gayou O; Gurram K; Weiss B; Thakkar S; Kirichenko A
J Med Imaging Radiat Oncol; 2015 Aug; 59(4):499-506. PubMed ID: 25754023
[TBL] [Abstract][Full Text] [Related]
8. Superiority of a soft tissue-based setup using cone-beam computed tomography over a bony structure-based setup in intensity-modulated radiotherapy for prostate cancer.
Sato H; Abe E; Utsunomiya S; Kaidu M; Yamana N; Tanaka K; Ohta A; Obinata M; Liu J; Kawaguchi G; Maruyama K; Ayukawa F; Aoyama H
J Appl Clin Med Phys; 2015 Sep; 16(5):239–245. PubMed ID: 26699304
[TBL] [Abstract][Full Text] [Related]
9. Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy.
van Nunen A; van der Sangen MJC; van Boxtel M; van Haaren PMA
Tech Innov Patient Support Radiat Oncol; 2017; 3-4():30-36. PubMed ID: 32095564
[TBL] [Abstract][Full Text] [Related]
10. Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapy.
Shi J; Tang Y; Li N; Song Y; Wang S; Liu Y; Fang H; Lu N; Tang Y; Qi S; Chen B; Li Y; Liu W; Jin J
Radiat Oncol; 2022 Feb; 17(1):22. PubMed ID: 35115015
[TBL] [Abstract][Full Text] [Related]
11. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the amplitude changes and baseline shifts of respiratory motion using intra-fractional CBCT in liver stereotactic body radiation therapy.
Zeng L; Wang X; Zhou J; Gong P; Wang X; Wu X; Deng Z; Li B; Liu D; Zhong R
Phys Med; 2022 Jan; 93():52-58. PubMed ID: 34942458
[TBL] [Abstract][Full Text] [Related]
13. Planning target volume margin evaluation and critical structure sparing for rectal cancer patients treated prone on a bellyboard.
Cranmer-Sargison G; Kundapur V; Park-Somers E; Andreas J; Vachhrajani H; Sidhu NP
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):e17-22. PubMed ID: 22925598
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of Gold Fiducial Markers as a Surrogate for Gross Tumor Volume Position in Image-Guided Radiation Therapy of Rectal Cancer.
van den Ende RPJ; Kerkhof EM; Rigter LS; van Leerdam ME; Peters FP; van Triest B; Staring M; Marijnen CAM; van der Heide UA
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1151-1159. PubMed ID: 31476419
[TBL] [Abstract][Full Text] [Related]
15. Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer.
Levin-Epstein R; Qiao-Guan G; Juarez JE; Shen Z; Steinberg ML; Ruan D; Valle L; Nickols NG; Kupelian PA; King CR; Cao M; Kishan AU
Front Oncol; 2020; 10():539. PubMed ID: 32373529
[No Abstract] [Full Text] [Related]
16. Set-Up Errors, Organ Motion, Tumour Regression and its Implications on Internal Target Volume-Planning Target Volume During Cervical Cancer Radiotherapy: Results From a Prospective Study.
Mahantshetty U; Naga P; Nachankar A; Ghadi Y; Dheera A; Scaria L; Epili D; Chopra S; Lavanya G; Shrivastava S
Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):189-197. PubMed ID: 34736842
[TBL] [Abstract][Full Text] [Related]
17. Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy.
Munoz F; Fiandra C; Franco P; Guarneri A; Ciammella P; De Stefanis P; Rondi N; Moretto F; Badellino S; Iftode C; Ragona R; Ricardi U
Radiol Med; 2012 Sep; 117(6):1057-70. PubMed ID: 22327924
[TBL] [Abstract][Full Text] [Related]
18. The impact of the three degrees-of-freedom fiducial marker-based setup compared to soft tissue-based setup in hypofractionated intensity-modulated radiotherapy for prostate cancer.
Tanabe S; Utsunomiya S; Abe E; Sato H; Ohta A; Sakai H; Yamada T; Kaidu M; Aoyama H
J Appl Clin Med Phys; 2019 Jun; 20(6):53-59. PubMed ID: 31054217
[TBL] [Abstract][Full Text] [Related]
19. Quantifying motion for pancreatic radiotherapy margin calculation.
Whitfield G; Jain P; Green M; Watkins G; Henry A; Stratford J; Amer A; Marchant T; Moore C; Price P
Radiother Oncol; 2012 Jun; 103(3):360-6. PubMed ID: 22410203
[TBL] [Abstract][Full Text] [Related]
20. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.
Su Z; Li Z; Henderson R; Hoppe B; Nichols RC; Bryant C; Mendenhall W; Mendenhall N
Phys Med Biol; 2019 Feb; 64(4):04NT04. PubMed ID: 30630135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
